Stocks and Investing
Stocks and Investing
Tue, May 29, 2012
[ 06:46 AM ] - United States, Market Wire
[ 06:39 AM ] - United States, Market Wire
[ 06:38 AM ] - United States, Market Wire
[ 06:24 AM ] - United States, Market Wire
[ 06:05 AM ] - United States, Market Wire
[ 06:00 AM ] - United States, Market Wire
[ 05:40 AM ] - United States, WOPRAI
[ 05:31 AM ] - United States, Market Wire
[ 05:11 AM ] - United States, Market Wire
[ 05:00 AM ] - United States, Market Wire
[ 05:00 AM ] - United States, Market Wire
[ 04:02 AM ] - United States, WOPRAI
[ 04:02 AM ] - United States, WOPRAI
[ 04:01 AM ] - United States, WOPRAI
[ 04:01 AM ] - United States, WOPRAI
[ 04:00 AM ] - United States, Market Wire
[ 04:00 AM ] - United States, WOPRAI
[ 02:40 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Risinger Maintained (TEVA) at Hold with Decreased Target to $44 on, May 29th, 2012
David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $47 to $44 on, May 29th, 2012.
David has made no other calls on TEVA in the last 4 months.
There is 1 other peer that has a rating on TEVA. Out of the 1 peers that are also analyzing TEVA, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Liav Abraham of "Citigroup" Maintained at Strong Buy with Decreased Target to $49 on, Friday, May 25th, 2012
Contributing Sources